COLUMN: Surveys bring Thanksgiving | Opinion | montrosepress.com – Montrose Daily Press
Posted: November 26, 2020 at 2:50 am
The arrival every October of a survey from the long-term follow-up care unit (LTFU) at the Fred Hutchinson Cancer Care Alliance in Seattle sets in motion a routine. I walk it back from the mailbox, putting it on the kitchen table where it sits unopened for four or five days. Then its moved to the dining room table where it sits for another few days. Then its taken downstairs, still unopened, where its put in a stack of other stuff for a week-plus. The routine continues when a follow-up to the follow-up comes in the mail.
Paraphrasing, the second LTFU letter reads: cmon, man. Take 15 minutes, fill it out, mail it back. Which I do. Could this be avoidance behavior, as per psychologists? Quoting Bill Murray, the casual philosopher, (Stripes, 1981), thats a fact, Jack!
Ive been in remission for 17 years after a stem cell transplant from the Hutch a day after my 51st birthday. The LTFU began following patients in 1990, citing improvement in the mortality of transplantation.
There are about 6,800 people enrolled currently in LTFU. In 2019, 4,764 former patients received the survey and about half of them returned it, said Molly McElroy, the communications director for the Hutch. She added how theres one transplant patient ambulatory and upright from 1971; 100-plus from before 1980.
I was diagnosed in 1998 with a friendly leukemia, but during an annual checkup a few years later, the diagnosis changed, and: the prognosis isnt as promising.
Conversations like that are ineradicable, along with related reminiscences of hallway walks with chemo poles and technicians who warn, youre going to feel a little prick. This is before they draw blood or remove bone marrow. (The first time I heard it, I thought it funny; after the umpteenth, not so much.) Treatment of mantle cell lymphoma required difficult, four-cocktail, hospitalized chemotherapy at St. Marys in Grand Junction. Soon thereafter, we left for the Hutch and transplant.
Hokey and contrived as it sounds, remission from cancer is indeed about some of the people you meet along the way.
Lee Bradley fruit farmer, wine maker, country marketer, located in the northern suburbs of Paonia calmed the hothouse of my mind after diagnosis. We talked about what was coming, sharing common stories about doctors, the Hutch, the determination of it all. Last month, Bradley celebrated 20 years of good health. (His familys market, which sits alongside the north fork of the Gunnison river, is a good place to grab an easy chair and enjoy a summers day under the cottonwoods.)
Early on at the Hutch, a physician who looked like she had just left a Grateful Dead concert with her long hair, granny-glasses and leather-fringed jacket, calmly explained options. Including a clinical trial for which she had written the protocol. As a result, Im still getting mail from the LTFU. Dr. Leona Holmberg, MD, PhD., continues to get it done as a physician, researcher and oncology professor at the U. of Washington.
We also met a nattily dressed doctor with great humor. He was placing into my chest a dual Hickman catheter which would expeditiously transport stem cells, chemo, nutrition, blood products and whatever else. (A terrific invention, but not a good look on a beach. It flops around a lot.) He flirted good-naturedly with Susan, who was maybe 10 inches taller. Are you the same guy whose name is on this? I cracked wise about him getting a commission; smiling, he replied that hed done all right. Dr. Robert O. Hickman, who was a founding member of the Hutch bone marrow transplant team, died last year at 92, his invention still widely used.
After transplant, my blood counts were stubbornly stuck at zero. The body language of the doctor-posse when they rolled through my room in the mornings wasnt encouraging. Then I caught an infection and spent 10 days in isolation. My nurse recognized despair. On a rainy Saturday afternoon, she sat on the bed and without saying a word, pulled me close. For less than a minute. She likely broke a slew of HR rules, but Corinne Vaniers humanity was the tonic. The next day, my counts started to move north. Ten years after the transplant, we had lunch in Seattle and continue to be in touch.
Julia Vega, the daughter of longtime friends and a newspaper publisher pal, was a year younger than our son. She had a pelvic cancer and enjoyed some initial remission. Her dad and I shared stories about the Hutch, the Pete Gross House (apartments) and Dr. Holmberg, also her physician.
Vega was a theater student at Arizona State U. when diagnosed and instead of dropping out and taking it easy, she forged through doing the chemo, going to classes, participating in productions, graduating. I enjoyed her company as a middle schooler in North Carolina, and again at a newspaper convention where she accompanied her father, fragile thin and wearing a wig. We have a photo together from that meeting. Whenever I hear one of her favorite songs, Bob Dylans Shooting Star, I recall her grace.
A story about Chris Mesaric was framed and placed along the walls of a Hutch examination clinic. My brother and I had flown to Seattle to nail down the second opinion and I happened on it while he was wrapping up a conversation with yet another oncologist. Mesaric had grown up here, MHS Class of 1987, and had worked as an airframe mechanic for Boeing in Seattle before returning to Montrose. The docs had given him little chance in 1992 of surviving aplastic anemia, a rare bone marrow disease. He was also told that there would be no children, either. Yet he and Robin are the parents of two lovely daughters.
Mesarics brave fight went on for 11 years, receiving a Hutch transplant in 2001. He was inspirational, although we never met. We left the Hutch after five months, arriving home the day before Thanksgiving, 2003; Mesaric, 35, passed three weeks later. I know his folks, Frank and Linda Mesaric, and whenever I see Frank around town, his big, welcoming voice is at once a comfort and a knowing.
There were good times, of course, during the procedures, before the transplant. Routines that got us away from the grimness. After morning bloodwork, we had a daily 16-block hike to the Barnes & Noble bookstore in downtown Seattle. One day, former Sen. Gary Hart was spotted in the shelves, browsing, and we chatted. There were plenty of windows to look into, galleries of all sorts, and all the bits and bobs and fish tossing from the Pike Place Market. Even a free monorail to ride. We enjoyed a couple of nights out with live music at Dimitrious Jazz Alley. William visited from Alaska and the three of us caught a Mariners/White Sox game at Safeco Field. Ryanns down-the-elevator, in-the-building interim school provided friendships and field trips. There was retail therapy. The downtown flagship Nordstroms store provided almost 400,000 square feet of distraction and attraction. (After we returned to Montrose, they had to lay off the lobbys pianist. Jes kidding.)
Theres a picture of the four of us on the refrigerator from Day One. Bald and bloated, Im unrecognizable. After Susan declared we can do this, upon turning that apartments front door key, thats when the recovery, like the new bone marrow, began to graft itself.
The piece of mail in October confirms it. Im thankful for those follow-up people who still have my address.
View original post here:
COLUMN: Surveys bring Thanksgiving | Opinion | montrosepress.com - Montrose Daily Press
- Unlocking The Unlimited Potential Of Stem Cells - CodeBlue - January 9th, 2021
- Hemostemix steps into the new year with capital and its critical clinical study data in hand - InvestorIntel - January 9th, 2021
- Global Organ and Tissue Transplantation and Alternatives Market to 2024 - Impact Analysis of COVID-19 - Yahoo Finance - January 9th, 2021
- Top 10 ALS Stories of 2020 - ALS News Today - January 9th, 2021
- Brave West Lothian women discovers back pain is actually deadly blood cancer - Daily Record - January 9th, 2021
- Global Bone Marrow Aspirate Concentrates (BMAC) Market : Industry Analysis and forecast (2019 to 2026): By product Type, Application, End Users, and... - January 9th, 2021
- Creative Medical Technology Holdings Announces Successful Application of ImmCelz Immunotherapy for Treatment of Stroke - PRNewswire - December 22nd, 2020
- Organ and Tissue Transplantation and Alternatives - GlobeNewswire - December 22nd, 2020
- How Researchers Are Making Do in the Time of COVID-19 - The Wire Science - December 22nd, 2020
- FDA Resumes eIND Approval for Severe-to-Critical COVID-19 Patients Use of Vyrologix (leronlimab) Following Full Enrollment in CytoDyn's Phase 3 Trial... - December 22nd, 2020
- Priming the Immune System to Fight Cancer - PRNewswire - December 22nd, 2020
- The 11 most mind-blowing, awe-inspiring health discoveries and innovations of 2020 - Business Insider - Business Insider - December 22nd, 2020
- Orchard Therapeutics Receives EC Approval for Libmeldy for the Treatment of Early-Onset Metachromatic Leukodystrophy (MLD) - GlobeNewswire - December 22nd, 2020
- Creative Medical Technology Stock Price Increased 80.77%: Why It Happened - Pulse 2.0 - December 22nd, 2020
- Digenic mutations in ALDH2 and ADH5 impair formaldehyde clearance and cause a multisystem disorder, AMeD syndrome - Science Advances - December 22nd, 2020
- Creative Medical Technology Holdings Announces Successful Application of ImmCelz Immunotherapy for Treatment of Stroke - KPVI News 6 - December 16th, 2020
- Novel class of targeted cancer therapies could treat myeloid leukaemias - Drug Target Review - December 16th, 2020
- 1st Patients To Get CRISPR Gene-Editing Treatment Continue To Thrive - NPR - December 16th, 2020
- Bone Regeneration Material Market: Cell-based Segment to Expand Significantly - BioSpace - December 16th, 2020
- Shingles: What triggers this painful, burning rash? - Harvard Health Blog - Harvard Health - December 16th, 2020
- Impact of Covid-19 On Orthopedic Regenerative Medicine Market Business Overview and Forecast to 2027 | Curasan, Inc., Carmell Therapeutics... - December 16th, 2020
- Early Signs of Activity and Tolerability Found in Allogeneic Product UCART22 for Patients with Relapsed/Refractory CD22+ B-Cell ALL - Cancer Network - December 16th, 2020
- Updated Findings Show Continued Efficacy for CAR T-Cell Therapy in Heavily Pretreated Myeloma - Targeted Oncology - December 16th, 2020
- Haywards Heath woman's bid to fund stem cell treatment to combat MS - Mid Sussex Times - December 16th, 2020
- Stem Cell Transplant Reduces Relapses and Disability in RRMS... - Multiple Sclerosis News Today - December 11th, 2020
- Gamida Cell Provides Pipeline Update, Including Detailed Results of Pivotal Phase 3 Clinical Study of Omidubicel, and Prepares to Start BLA Submission... - December 11th, 2020
- Groundbreaking Trial On Children With Brain Injuries In Madrid - Euro Weekly News - December 11th, 2020
- Actinium Highlights Iomab-B Safety Data Presented at the 62nd American Society of Hematology Annual Meeting - Yahoo Finance - December 11th, 2020
- Antileukemic Activity Seen With Flotetuzumab in Primary Induction Failure, Early-Relapse AML - Hematology Advisor - December 11th, 2020
- SNUH finds way to produce T-cells to prevent HSCT complications - Korea Biomedical Review - December 11th, 2020
- CLL patients in England to get AZ's Calquence after okay from NICE - - pharmaphorum - December 11th, 2020
- JP Duminy goes to bat for the SA Bone Marrow Registry - IOL - December 10th, 2020
- Donor Stem Cell Transplant Improves Survival in Older Patients with Myelodysplastic Syndrome - Cancer Health Treatment News - December 10th, 2020
- City of Hope Doctors Present Innovative Therapies to Better Treat Blood Cancers at American Society of Hematology Virtual Conference - Business Wire - December 10th, 2020
- Jasper Therapeutics Announces Data from First Transplant-naive Patient in Phase 1 Clinical Trial of JSP191 as Conditioning Agent in Patients with SCID... - December 10th, 2020
- Bid to fund stem cell treatment in Mexico for woman with MS - Bournemouth Echo - December 10th, 2020
- The Technology Behind Bone Marrow Cellular Processing: The PXP System - Marketscreener.com - December 10th, 2020
- ElevateBio's HighPassBio Presents on Novel T Cell Receptor Cell Therapy for Leukemia Relapse at 62nd Annual ASH Meeting - Business Wire - December 10th, 2020
- Gene Therapy, Absolutely and For Real | In the Pipeline - Science Magazine - December 10th, 2020
- Negrin Shines Light on the Orca-T Story in GVHD - OncLive - December 10th, 2020
- Researchers Trace the Origin of Blood Cancer to Early Childhood, Decades before Diagnosis - PRNewswire - December 10th, 2020
- Magenta Therapeutics Announces Commencement of First Phase 2 Clinical Trial of MGTA-145 for Stem Cell Mobilization, Oral Presentation of MGTA-145... - December 10th, 2020
- Hadassah Medical Center and Neurogenesis Announce Groundbreaking Results from a Phase 2 Study in Progressive Multiple Sclerosis treated with NG-01... - December 10th, 2020
- Rocket Pharmaceuticals Presents Positive Clinical Data from its Fanconi Anemia and Leukocyte Adhesion Deficiency-I Programs at the 62nd American... - December 10th, 2020
- Venetoclax/Azacitidine Combination Efficacious for the Treatment of Older Patients With Higher-Risk Myelodysplastic Syndrome - Oncology Nurse Advisor - December 10th, 2020
- Precigen Presents New Data Supporting the Safety, Clinical Activity, Expansion and Persistence of PRGN-3006 UltraCAR-T at the 62nd ASH Annual Meeting... - December 10th, 2020
- BeyondSpring Announces New Positive PROTECTIVE-2 Phase 3 Registrational Trial Results at the 2020 San Antonio Breast Cancer Symposium - BioSpace - December 10th, 2020
- Joliet 2-year-old gets pre-holiday gift: tests that show he's cancer-free - The Herald-News - December 10th, 2020
- Preliminary Results from NexImmune's Phase 1/2 Trial of NEXI-001 in AML Presented at 62nd ASH Annual Meeting and Exposition - GlobeNewswire - December 10th, 2020
- How do you donate stem cells? Donating cells can help treat cancer, blindness and other conditions - heres how - The Scotsman - December 4th, 2020
- Repairing the Brain With Stem Cells? A Conversation With Prof. Jack Price - Being Patient - December 4th, 2020
- Treatment to restore vision by injecting stem cells into the eye could help people with damaged eyesight - iNews - December 4th, 2020
- Sphingosine 1-phosphate Receptor Modulator ONO-4641 Regulates Trafficking of T Lymphocytes and Hematopoietic Stem Cells and Alleviates Immune-Mediated... - December 4th, 2020
- Cancer center is a contributor to 49 research studies at the 62nd American Society of Hematology Annual Meeting - Newswise - December 4th, 2020
- IN8bio announces first-in-human Phase 1 trial Update from The University of Kansas Cancer Center using INB-100, IN8bios Gamma Delta T-cell product... - December 4th, 2020
- Bone Marrow Transplant Market Size, Segmented by Type of Deployment, Application, And Region Growth, Trends, And Forecast - The Haitian-Caribbean... - December 4th, 2020
- Gut bacteria can help rebuild the immune system - Medical News Today - December 4th, 2020
- InvestmentPitch Media Video Discusses Hemostemix Successfully Obtaining all Clinical Trial Data and Announcement of $2.5 Million Unit Offering - Video... - December 4th, 2020
- Outlook on the Multiple Myeloma Drugs Global Market to 2025 - by Therapy, Drug Type, End-user, Distribution Channel and Region -... - December 4th, 2020
- Imago BioSciences Expands Phase 2 Clinical Trial of Bomedemstat (IMG-7289) for the Treatment of Myelofibrosis into Hong Kong - Business Wire - December 4th, 2020
- The New Coronavirus Vaccine Is Changing The Future Of Medicine - Forbes - December 4th, 2020
- Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous... - November 30th, 2020
- How are bones and the heart connected? - British Heart Foundation - November 30th, 2020
- Telix Pharmaceuticals Limited Acquires TheraPharm GmbH, Broadening Reach to Hematologic Cancers and Transplant Medicine - BioSpace - November 30th, 2020
- Global Hematopoietic Stem Cell Transplantation (HSCT) Market 2020 Impact of COVID-19, Future Growth Analysis and Challenges | Regen Biopharma Inc,... - November 30th, 2020
- Coronavirus Updates: The Latest Treatments and Vaccines - GovTech - November 30th, 2020
- Hematopoietic Stem Cell Transplantation (HSCT) Market To Witness Huge Growth By 2027 | Regen Biopharma Inc, China Cord Blood Corp, CBR Systems Inc,... - November 30th, 2020
- Bone Marrow Processing Systems Market Top Participant to Focus on Regional Expansion - Murphy's Hockey Law - November 30th, 2020
- Family 'over the moon' as nine-year-old Aurora confirmed as being back in remission - The Isle of Thanet News - November 30th, 2020
- Pilot study finds potential signal indicative of loss of tone in blood vessels after cardiac surgery - The Hindu - November 30th, 2020
- Family's joy as schoolgirl, 9, back in remission - Kent Online - November 30th, 2020
- Family's heartache after Hebburn boy diagnosed with one in a million condition - Chronicle Live - November 30th, 2020
- Raleigh man delivers stem cells to patients around the world - WRAL.com - November 28th, 2020
- US FDA Approves Naxitamab for the Treatment of Neuroblastoma - OncoZine - November 28th, 2020
- The roles bone marrow plays in the body - Therogersvillereview - November 27th, 2020
- Severe Infections Wreak Havoc on Mouse Blood Cell Production - Technology Networks - November 27th, 2020
- Revenue from the Sales of Hematopoietic Stem Cells Transplantation Market to Witness Relatively Significant Growth During 2017 2025 - Canaan Mountain... - November 27th, 2020
- Approval of Phase I/II Clinical Trial of ATG-016 (Eltanexor), a Second Generation Selective Inhibitor of Nuclear Export (SINE), in Mainland China for... - November 27th, 2020
- Meet 'Iron Boy': Hempfield Twp. boy fighting cancer is real superhero - Gettysburg Times - November 27th, 2020
- G1 Therapeutics: Depressed Price Before Catalyst, No Apparent Reason - Seeking Alpha - November 27th, 2020